Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Paul Edison, Eleni Frangou et al.|Trials|2019Cited by 214
Evaluation of liraglutide in the treatment of Alzheimer's diseasePaul Edison, Clive Ballard, Grazia Daniela Femminella et al.|Alzheimer s & Dementia|2021Cited by 72
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trialPatrick G. Kehoe, Bernadette McGuinness, Ian B. Wilkinson et al.|The Lancet Neurology|2021Cited by 59
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?Grazia Daniela Femminella, Paul Edison, Nicholas R Livingston et al.|Alzheimer s Research & Therapy|2021Cited by 59
Liraglutide in mild to moderate Alzheimer’s disease: a phase 2b clinical trialPaul Edison, Clive Ballard, Grazia Daniela Femminella et al.|Nature Medicine|2025Cited by 41